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Oral Presentations S243collections were performed (2009, N 5 17; 2010, N 5 28; 2011,
N 5 17). Areas of consistent compliance were infectious disease
markers and laboratory work (essentially 100%). Areas needing
improvement included donor’s blood transfusion history
(76%), signing ‘‘Release of Medical Records’’ form (11%), con-
sent documented (70%), clearance in both recipient and donor’s
MR documented (41%, 29% respectively), and abnormal results
being reviewed with follow-up recommendations (25%). To im-
prove compliance and quality of care, a checklist was designed
to help the transplant coordinator (TC) review the required
documentation, labs, and consents needed prior to donor begin-
ning mobilization or recipient beginning preparative regimen. A
new Donor Advocacy prototype was developed and imple-
mented by our program in 2011. This model created a unique
donor medical team, comprised of a separate Related Donor
Coordinator and physician. The purpose of this model is to
avoid conflict of interest, provide unbiased care to the donor,
and provide ONE dedicated TC to care for ALL related do-
nors. With the instigation of these unique programmatic
changes, an increase in compliance with donor clearance in all
aspects, close to 100% in 2011, was obtained from medical
and regulatory perspectives. We persist in auditing quarterly
as donor standards continue to evolve.TRANSPLANT NURSING ORAL: RESEARCH106
YOUNG ADULT HEMATOPOIETIC TRANSPLANT PATIENTS’ DESCRIPTIVE
THEMES
Grant, M., Cooke, L. City of Hope, Duarte, CA
Purpose: Few studies address psychological issues for adoles-
cents and young adult (AYA) following Hematopoietic Cell
Transplantation (HCT). This study 1) describes the allogeneic
transplant experience for AYA transplant patients during the first
year following transplantation, and 2) presents AYA data ob-
tained during and following a six-part post transplant discharge
study.
Methods: The design is a mixed-methods longitudinal clinical trial
testing the effects of a standardized teaching intervention on quality
of life outcomes for allogeneic HCT patients at discharge, 3, 6, and
12 months post hospitalization. The sample consisted of 24 AYA pa-
tients, a subset of the total sample of 282 allogeneic hematopoietic
transplant patients recruited from one large medical center on the
Western Coast of the United States. The subset is divided into par-
ticipants from the intervention (N 5 10) and control (N 5 14)
groups.
Results: Quantitative Data: The mean age of AYA patients at the
time of transplant was 21.5, 11 were male and 13 were female;
13 patients were Hispanic, 19 were Caucasians, and 5 were Asian.
Most of the patients admitted for transplant had a diagnosis of
acute leukemia (83.5%), and had a sibling transplant (62.5%).
For conditioning, 70.8% of the patients had full myelosuppression,
and 29.2% had reduced intensity. Fifteen were in remission
whether it was first, second or third remission. Readmission data
and reasons for readmission will be presented.
Qualitative Data: Content analysis was used to analyze patient
comments during and following the 6-part teaching interven-
tion. Themes identified included: Sexuality/Fertility, fatigue,
depression/poor coping/habits, adherence issues, use of technol-
ogy, dependency issues, changes in roles/relationships, issues
with school/education, financial issues, family problems/issues,
religion/spirituality, fear of future, uncertainty, life, death, and
more life appreciation.
Conclusions: Young adult transplant patients have significant is-
sues, some unique to the AYA population.
Research Implications:: Findings provide useful data in treating
tailored educational approaches and support for AYAs undergoing
transplant.Clinical Implications:: The themes from the content analysis high-
light the young adult issues in the context of developmental stages for
the young adult. Clinical care using developmental stages can assist
in providing targeted education.
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SLEEP DISTURBANCES DURING HOSPITALIZATION FOLLOWING
HEMATOPOIETIC STEM CELL TRANSPLANTATION
Hacker, E.D.1, Larson, J.L.2, Ferrans, C.E.1 1University of Illinois at
Chicago, Chicago, IL; 2University of Michigan, Ann Arbor, MI
People receiving high-dose chemotherapy followed by hemato-
poietic stem cell transplantation (HSCT) frequently report sleep
disturbances during the acute phase of treatment. Although the re-
ported prevalence is high, objective documentation of disturbed
sleep patterns is lacking. This study employed subjective and ob-
jective sleep assessments to evaluate sleep patterns and examine re-
lationships among sleep patterns, quality of life, and demographic
factors. The convenience sample consisted of 40 hospitalized
HSCT patients. Each subject wore a wrist actigraph for five
days to assess sleep patterns (total sleep time, sleep onset latency,
sleep efficiency, wake after sleep onset, and number of awaken-
ings). At the end of the five-day period, subjects completed a qual-
ity of life questionnaire that included a sleep disturbance item
(EORTC QLQ C-30). Study results indicate there is a high prev-
alence of sleep disturbances during hospitalization following
HSCT. Eighty two percent of subjects reported some sleep distur-
bance. The mean total sleep time per 24-hour period was 5:41
hours (SD 5 2:21 hours) and sleep efficiency, 55% (SD 5
10%). A major sleep interval (more than 3 hours) normally occurs
within each 24-hour period; however, 35% of subjects did not ex-
perience a major sleep interval during one or more 24-hour pe-
riods. HSCT subjects older than 60 spent significantly more
time attempting to fall asleep compared to those between the
ages of 18 and 39 (p\ .05). Subjects experienced frequent awak-
enings during sleep intervals (M 5 28; SD 5 13, per 24-hour pe-
riod). Total sleep time was moderately correlated with pain (r 5
.363, p\ .05) and dyspnea (r 5 .372, p\ .05). Subjective assess-
ment of sleep negatively correlated with age (r 5 -.375, p\ .05)
and cognitive function (r 5 -.380, p\ .05) while positively corre-
lated with pain (r 5 .327, p\ .05).
Conclusions: Findings suggest that a substantial number of
HSCT patients experience sleep disturbances during the acute
phase of HSCT treatment. Reductions in total sleep time were
associated with increased pain and dyspnea. Older HSCT pa-
tients spend more time trying to fall asleep while younger pa-
tients are more likely to complain of sleep disturbances. As
sleep is an essential biological function, additional research is
needed regarding the effects of sleep disturbances on recovery
following HSCT and interventions to optimize sleep during
hospitalization.108
SUPPORTING OF PARENTS DURING THEIR CHILD’S ALLOGENEIC STEM
CELL TRANSPLANTATION DEPENDS ON THEIR PARENTAL TYPE
Larsen, H.B.1, Heilmann, C.1, Johansen, C.2, Adamsen, L.3 1Rigshospita-
let, Copenhagen, Denmark; 2Danish Cancer Society, Copenhagen, Den-
mark; 3Rigshospitalet, Copenhagen, Denmark
Background: Parents to children undergoing treatment with alloge-
neic stem cell transplantation (HSCT) are highly involved in the care
of their children. However, parents have different care approaches
and conflicts may arise when discrepancies occur between the par-
ents’ rationality and the hospital systems’ standards of care.
Materials and Methods: In the period 2007-2009, 25 parents par-
ticipated in an observational study during the child’s inpatient
